Patricia W. H. Hugen

Author

Also Known As

P W Hugen, P W.H. Hugen, P.W.H. Hugen, PATRICIA W. H. HUGEN, Patricia Hugen, Patricia W. H. Hugen, Patricia W.H Hugen, Patricia W.H. Hugen, Patricia WH Hugen

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Slotervaartziekenhuis Leiden University Medical Center Rijnstate Hospital

About

Patricia W. H. Hugen is an author at Radboud University Nijmegen specializing in medicine, hiv, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	563
2	Language Studies	1	1	20
3	Public Health	1	1	13
4	Biochemistry	1	1	27
5	Comparative Literature	1	1	20

Patricia W. H. Hugen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy David M. Burger, Richard M. W. Hoetelmans, Patricia W. H. Hugen, Antiviral Therapy Virological Treatment FailureTreatment And PreventionIndinavir-containing Triple TherapyLow Plasma ConcentrationsIndinavir Plasma Concentrations	1998	161
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals David M. Burger, Patricia W. H. Hugen, Peter Reiss, AIDS	2003	147
Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring Patricia W. H. Hugen, Nienke Langebeek, David M. Burger, JAIDS Journal of Acquired Immune Deficiency Syndromes	2002	127
Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, David M. Burger, Journal of Chromatography B Biomedical Sciences and Applications MedicineBioanalysisAntiviral TherapyVirologyHuman Plasma	1999	107
Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure Patricia W. H. Hugen, David M. Burger, Kees Brinkman, Annals of Pharmacotherapy	2000	85
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients Patricia A. Baede-van Dijk, Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, AIDS	2001	69
Simultaious determination of the HIV protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, David M. Burger, Data Archiving and Networked Services (DANS) MedicineHiv Protease InhibitorsBioanalysisAntiviral Drug DevelopmentAntiviral Therapy	1999	69
Treatment Failure of Nelfinavir-Containing Triple Therapy Can Largely Be Explained by Low Nelfinavir Plasma Concentrations David M. Burger, Patricia W. H. Hugen, Rob E. Aarnoutse, Therapeutic Drug Monitoring Diagnostic VirologyNeurovirologyMinimum Effective ConcentrationAntiviral TherapyImmunology	2003	68
The influence of efavirenz on the pharmacokinetics of a twice‐daily combination of indinavir and low‐dose ritonavir in healthy Volunteers Rob E. Aarnoutse, Karin Grintjes, Denise Telgt, Clinical Pharmacology & Therapeutics	2002	61
A Retrospective, Cohort-Based Survey of Patients Using Twice-Daily Indinavir + Ritonavir Combinations: Pharmacokinetics, Safety, and Efficacy David M. Burger, Patricia W. H. Hugen, Rob E. Aarnoutse, JAIDS Journal of Acquired Immune Deficiency Syndromes	2001	46

Page 1